Exchange: NASDAQ·Updated 08:14 AM EDT

DCOY Decoy Therapeutics Inc.

$3.04
$0.06
(2.01%)
Pre-Market
Prev Close $2.98
Mkt Cap$1.95M
Vol454.00

About DCOY

Decoy Therapeutics, Inc. operates as a preclinical-stage biotechnology company. It engages in leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company was founded by Frederick E. Pierce, Barbara Hibner, Peter Marschel, Michael Lipp, and Jodi Cooper in 2020 and is headquartered in Houston, TX.
39

Bearish Sentiment

How do you feel about DCOY?

Advertisement|Remove ads.